PAMCX
Price
$95.39
Change
+$1.10 (+1.17%)
Updated
Oct 13 closing price
Net Assets
26.12B
STMGX
Price
$34.65
Change
+$0.71 (+2.09%)
Updated
Oct 13 closing price
Net Assets
742.32M
Interact to see
Advertisement

PAMCX vs STMGX

Header iconPAMCX vs STMGX Comparison
Open Charts PAMCX vs STMGXBanner chart's image
T. Rowe Price Mid-Cap Growth Adv
Price$95.39
Change+$1.10 (+1.17%)
VolumeN/A
Net Assets26.12B
American Beacon Stephens Mid-Cap Gr I
Price$34.65
Change+$0.71 (+2.09%)
VolumeN/A
Net Assets742.32M
PAMCX vs STMGX Comparison Chart in %
View a ticker or compare two or three
VS
PAMCX vs. STMGX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Buy and STMGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 26.1B vs. STMGX (742M). PAMCX (0.00) and STMGX (0.00) have matching dividends . PAMCX was incepted earlier than STMGX: PAMCX (26 years) vs STMGX (20 years). STMGX (1.22) is less costly to investors than PAMCX (1.01). STMGX is a more actively managed with annual turnover of: 24.00 vs. PAMCX (22.60). PAMCX (2500) and STMGX (2500) have matching initial minimum investment requirements. STMGX annual gain was more profitable for investors over the last year : 8.12 vs. PAMCX (-9.35). STMGX return over 5 years is better than : 22.57 vs. PAMCX (-8.09).
PAMCXSTMGXPAMCX / STMGX
Total Expense Ratio1.011.1687%
Annual Report Gross Expense Ratio1.011.2283%
Fund Existence26 years20 years-
Gain YTD0.35111.7183%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets26.1B742M3,518%
Annual Yield % from dividends0.000.00-
Returns for 1 year-9.358.12-115%
Returns for 3 years19.4858.9733%
Returns for 5 years-8.0922.57-36%
Returns for 10 years21.54103.0221%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATHE4.660.37
+8.62%
Alterity Therapeutics Limited
SB4.270.13
+3.14%
Safe Bulkers
LFST5.110.06
+1.19%
LifeStance Health Group
FDS285.992.86
+1.01%
Factset Research Systems
CHR0.14-0.01
-4.76%
Cheer Holding